Abacus Planning Group, Inc. Abbott Laboratories Transaction History

Abacus Planning Group, Inc.

$545 Million
Q3 2024

A detailed history of Abacus Planning Group, Inc. transactions in Abbott Laboratories stock. As of the latest transaction made, Abacus Planning Group, Inc. holds 4,273 shares of ABT stock, worth $502,718. This represents 0.09% of its overall portfolio holdings.

Number of Shares

4,273

Previous 3,379 26.46%

Holding current value

$502,718

Previous $351,000 38.75%

% of portfolio

0.09%

Previous 0.07%

23 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Oct 02, 2024	BUY	$100.07 - $118.13 $89,462 - $105,608	894 Added 26.46%	4,273 $487,000
Q2 2024 Jul 30, 2024	BUY	$100.73 - $112.44 $302 - $337	3 Added 0.09%	3,379 $351,000
Q1 2024 Apr 11, 2024	SELL	$109.52 - $120.96 $23,108 - $25,522	-211 Reduced 5.88%	3,376 $383,000
Q4 2023 Jan 19, 2024	SELL	$90.19 - $110.4 $4,238 - $5,188	-47 Reduced 1.29%	3,587 $394,000
Q3 2023 Oct 11, 2023	SELL	$95.53 - $114.62 $5,349 - $6,418	-56 Reduced 1.52%	3,634 $351,000
Q2 2023 Jul 06, 2023	SELL	$100.78 - $112.29 $21,466 - $23,917	-213 Reduced 5.46%	3,690 $402,000
Q1 2023 Apr 17, 2023	BUY	$96.86 - $114.01 $20,631 - $24,284	213 Added 5.77%	3,903 $395,000
Q4 2022 Jan 19, 2023	SELL	$95.06 - $111.52 $5,703 - $6,691	-60 Reduced 1.6%	3,690 $0
Q3 2022 Oct 18, 2022	BUY	$96.76 - $112.03 $26,609 - $30,808	275 Added 7.91%	3,750 $363,000
Q4 2021 Jan 18, 2022	BUY	$115.53 - $141.46 $25,070 - $30,696	217 Added 6.66%	3,475 $489,000
Q3 2021 Oct 19, 2021	SELL	$116.66 - $129.06 $2,333 - $2,581	-20 Reduced 0.61%	3,258 $385,000
Q2 2021 Jul 20, 2021	SELL	$105.79 - $124.53 $12,694 - $14,943	-120 Reduced 3.53%	3,278 $380,000
Q1 2021 Apr 27, 2021	BUY	$108.84 - $128.23 $37,332 - $43,982	343 Added 11.23%	3,398 $407,000
Q4 2020 Feb 01, 2021	SELL	$105.0 - $114.42 $6,615 - $7,208	-63 Reduced 2.02%	3,055 $335,000
Q3 2020 Nov 03, 2020	BUY	$91.64 - $111.29 $5,498 - $6,677	60 Added 1.96%	3,118 $339,000
Q2 2020 Aug 11, 2020	BUY	$76.57 - $98.0 $7,656 - $9,800	100 Added 3.38%	3,058 $280,000
Q1 2020 Apr 30, 2020	SELL	$62.82 - $91.86 $17,966 - $26,271	-286 Reduced 8.82%	2,958 $233,000
Q3 2019 Nov 01, 2019	BUY	$81.84 - $88.74 $7,611 - $8,252	93 Added 2.95%	3,244 $271,000
Q4 2018 Feb 15, 2019	SELL	$65.56 - $74.27 $3.65 Million - $4.13 Million	-55,642 Reduced 94.64%	3,151 $228,000
Q4 2018 Feb 14, 2019	BUY	$65.56 - $74.27 $3.65 Million - $4.13 Million	55,642 Added 1765.85%	58,793 $9.27 Million
Q3 2018 Oct 31, 2018	BUY	$60.81 - $73.36 $191,612 - $231,157	3,151 New	3,151 $231,000
Q1 2018 May 04, 2018	SELL	$56.27 - $63.62 $200,208 - $226,359	-3,558 Closed	0 $0
Q4 2017 Mar 06, 2018	BUY	$53.68 - $57.47 $190,993 - $204,478	3,558	3,558 $203,000

Others Institutions Holding ABT

# of Institutions

3,167

Shares Held

1.33B

Call Options Held

8.63M

Put Options Held

7.19M

View Full List

About ABBOTT LABORATORIES

Ticker ABT
Exchange NYSE
Sector Healthcare
Industry Medical Devices
Shares Outstandng 1,751,219,968
Market Cap $206B
Description
Abbott Laboratories, together with its subsidiaries, discovers, develops, manufactures, and sells health care products worldwide. It operates in four segments: Established Pharmaceutical Products, Diagnostic Products, Nutritional Products, and Medical Devices. The Established Pharmaceutical Products segment provides generic pharmaceuticals for t...

More about ABT

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Abacus Planning Group, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Abacus Planning Group, Inc. with notifications on news.

Account

Abacus Planning Group, Inc. Abbott Laboratories Transaction History